Pnina Fishman

Pnina Fishman

Company: Can-Fite BioPharma

Job title: Chief Executive Officer & Chief Scientific Officer


Targeting the A3 Adenosine Receptor for the Treatment of Advanced Liver Cancer 2:45 pm

• Understanding the rational of targeting the A3 adenosine receptor for the treatment of liver cancer • Utilizing the highly specific A3 adenosine receptor agonist namodenoson to inhibit liver cancer growth • Exploring the phase 2 study data and the phase 3 pivotol study protocolRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.